An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive, ever resilient nature. A major drawback lies in its tumor grade; a phenomenon observed across various carcinomas, where highly differentiated and undifferentiated tumor grades, termed as low and high gra...

Descripción completa

Detalles Bibliográficos
Autores principales: Aier, Imlimaong, Semwal, Rahul, Dhara, Aiindrila, Sen, Nirmalya, Varadwaj, Pritish Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797122/
https://www.ncbi.nlm.nih.gov/pubmed/31622355
http://dx.doi.org/10.1371/journal.pone.0223554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797122/
https://www.ncbi.nlm.nih.gov/pubmed/31622355
http://dx.doi.org/10.1371/journal.pone.0223554

Ejemplares similares